Despite these promising advancements, a systematic evaluation of how DHTs are integrated into rare disease trials remain lacking
An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics
Funding The authors are grateful to the National Key Research and Development Program of China (2022YFD1300701, 2019YFE0115000) and the China Agriculture Research System of MOF and MARA (CARS-41)
InfiniWell TRIO Ingredients InfiniWell TRIO Ingredients Aqua (Deionized Water), Helianthus Annuus (Sunflower) Oil, Dimethicone, Cetyl Alcohol, Stearyl Alcohol, Ceteareth-20, Propylene Glycol, Polyacrylamide, C13-14 Isoparaffin, Laureth-7, Acetyl Hexapeptide-8, Pentapeptide-18, Caprylyl Glycol, Copper Peptide, Isopropyl Myristate, Caprylic/Capric Triglyceride, Lecithin, Glycerin, Xanthan Gum, Tetrasodium EDTA, Phenoxyethanol, Ethylhexylglycerin
However, deployment of such technologies remains underexplored, particularly in the inherent urgent prehospital setting